Matthew Kennedy is Director of Neuroscience at Merck Research Laboratories in Boston, Massachusetts.
Segment
Read More
8:55
An Important Test for the Amyloid Hypothesis
The results of a Phase III clinical drug trial could reveal whether beta amyloid is at the root of Alzheimer’s disease.